Filing Details
- Accession Number:
- 0001486189-23-000027
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-09-08 12:18:53
- Reporting Period:
- 2023-08-25
- Accepted Time:
- 2023-09-08 12:18:53
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1870144 | Cardio Diagnostics Holdings Inc. | CDIO | In Vitro & In Vivo Diagnostic Substances (2835) | 870925574 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1950789 | Meeshanthini Dogan | 311 W Superior St, Ste 444 Chicago IL 60654 | Chief Executive Officer | Yes | Yes | Yes | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2023-08-25 | 1,770 | $0.56 | 111,864 | No | 4 | P | Indirect | See note(3) |
| Common Stock | Acquisiton | 2023-08-31 | 16,481 | $0.55 | 128,345 | No | 4 | P | Indirect | See note(3) |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Indirect | See note(3) |
| No | 4 | P | Indirect | See note(3) |
Footnotes
- The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions with prices ranging from $0.55 to $0.56 inclusive. The reporting person undertakes to provide to Cardio Diagnostics Holdings Inc., any security holder of Cardio Diagnostics Holdings Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range of footnote (1) to this Form 4.
- The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions with prices ranging from $0.54 to $0.55 inclusive. The reporting person undertakes to provide to Cardio Diagnostics Holdings Inc., any security holder of Cardio Diagnostics Holdings Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range of footnote (1) to this Form 4.
- These securities are held by the reporting person's spouse. The reporting person disclaims beneficial ownership of such securities except to the extent of her actual pecuniary interest therein.
Billionaire Hedge Funds
